Abstract:
The present invention provides methods of treating bone cancer, inducing differentiation of bone tumor cells, inhibiting bone tumor growth, inducing bone tumor regression or treating a hyperproliferative cell disorder by administering a pharmaceutically effective amount of a bone morphogenic protein or a nucleic acid encoding the bone morphogenic protein.
Abstract:
A self-watering and self-drying planter assembly (10) with a water reservoir (30) open to the air and a top downward system for supplying water into the soil through built-in water-feeding channels, (124, 126 and 128) each having a water-transfer control lever (136) for controlling the quantity of water supplied to the soil in the planter. There is an inner container assembly (100) including an inner container (20) for receiving a plant and soil, an outer container (300) spaced from and surrounding the inner container and defining therebetween a water-receiving chamber (30), and a water-supplying chamber (40) below for receiving water form said water-receiving chamber (30). A float assembly (218) automatically supplies water from the water-receiving chamber (30) to the water-supplying chamber (40).
Abstract:
Methods of inducing the expression of a Smad in a cell or tissue comprising the step of contacting the cell or tissue capable of expressing the Smad with a bone morphogenic protein are provided. Methods of inducing tissue formation and repairing a tissue defect or regenerating tissue, at a target locus in a mammal comprising the step of administering to the target locus a Smad are also provided.
Abstract:
The present invention provides methods and compositions for treating and repairing ligament defects using a bone morphogenic protein. The present invention provides methods of treating ligament defects, repairing ligament defects, forming ligament tissue, regenerating ligament tissue, and promoting growth of ligament tissue by transplanting into a patient in need thereof ligament cells cultured ex-vivo.
Abstract:
The present invention provides methods of treating bone cancer, inducing differentiation of bone tumor cells, inhibiting bone tumor growth, inducing bone tumor regression or treating a hyperproliferative cell disorder by administering a pharmaceutically effective amount of a bone morphogenic protein or a nucleic acid encoding the bone morphogenic protein.
Abstract:
Gene therapy methods for tissue formation, repair and regeneration using nucleic acids encoding morphogenic proteins and morphogenic protein stimulatory factors (MPSFs) are provided.
Abstract:
This invention relates to drug binding proteins, to genes encoding same and to assays and methods for screening pharmaceuticals. More specifically, this invention relates to a Cytokine Suppressive Anti-Inflammatory Drug (CSAID) binding protein, to a gene encoding same and to assays and screens useful in the evaluation and characterization of drugs of this pharmacologic class.
Abstract:
Gene therapy methods for tissue formation, repair and regeneration using nucleic acids encoding morphogenic proteins and morphogenic protein stimulatory factors (MPSFs) are provided.